540788 — Aspira Pathlab & Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹310.33m
- IN₹319.87m
- IN₹144.57m
Annual cashflow statement for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -51.7 | -42.4 | 13.8 | 44.6 | -0.887 |
| Depreciation | |||||
| Non-Cash Items | 7.07 | 7.73 | 9.15 | 7.61 | 2.17 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.5 | -0.602 | 19.3 | -48.3 | -17.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -33.9 | -18.7 | 56.7 | 20.3 | -0.12 |
| Capital Expenditures | -5.1 | -0.474 | -2.96 | -6.07 | -1.36 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -14.6 | 2.88 | 2.04 | 0.947 | 2.96 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -19.7 | 2.41 | -0.919 | -5.12 | 1.59 |
| Financing Cash Flow Items | -9.61 | -10.1 | -8.91 | -3.73 | -4.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 52.3 | 12.7 | -21.7 | -13.5 | -9.35 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.25 | -3.53 | 34.1 | 1.67 | -7.88 |